The global biotech industry is worth more than $1.8 trillion, but behind that number is something more powerful: the ability to save lives. And no one understands that better than today's guest, Dr. Peter Kash.
Over his 37-year career, Dr. Kash has helped bring seven FDA-approved drugs to market, including an important pediatric leukemia drug. He's raised billions in biotech capital, co-founded more than a dozen companies, and helped push cancer treatments from idea into execution.
Peter Kash is chasing cures. He's fighting for kids with brain cancer. He's accelerating AI-driven therapies for glioblastoma, Parkinson's, and Alzheimer's. And he believes that within eight years, solid tumor cancers like breast, prostate, and colorectal could have survival rates near 80%, just like today's blood cancers.
In a world of politics and profit, Peter is building something deeper: a global alliance of scientists, doctors, and entrepreneurs working together to outsmart disease.
So, if you care about medicine, humanity, or what the future could look like, this episode is your wake-up call. Because biotech isn't just about innovation. It's about the mother with ovarian cancer, the child with leukemia, the father battling Parkinson's. Peter, thank you for joining me on this episode of Some Future Day.
Episode Links:
Peter on LinkedIn: https://www.linkedin.com/in/peter-kash-a8736b14
Books by Dr. Peter Kash: https://www.amazon.com/stores/author/B01DH0AOY6
Peter's TedTalk: https://www.ted.com/talks/peter_kash_entrepreneurship_in_the_age_of_millennials/up-next
"Tatami" Official Trailer: https://www.youtube.com/watch?v=JHdzSTFslbI
Order Marc's new book, "Some Future Day: How AI Is Going to Change Everything"
Sign up for the Some Future Day Newsletter here: https://marcbeckman.substack.com/
To join the conversation, follow Marc Beckman here: